David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Meta Platforms (Facebook)
META
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
T-Mobile US
TMUS
|
+$416M |
| 5 |
Uber
UBER
|
+$350M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$547M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$490M |
| 3 |
Johnson & Johnson
JNJ
|
+$444M |
| 4 |
Apple
AAPL
|
+$435M |
| 5 |
Accenture
ACN
|
+$378M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.7% |
| 2 | Consumer Discretionary | 8.8% |
| 3 | Healthcare | 8.52% |
| 4 | Financials | 6% |
| 5 | Industrials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Sutro Biopharma
STRO
$340M
| $189K | ﹤0.01% |
4,072
-11,448
| -74% | -$570K |
|
3627
ClearPoint Neuro
CLPT
$463M
| $188K | ﹤0.01% |
+25,973
| New | +$221K |
|
3628
Senseonics Holdings Inc
SENS
$496M
| $186K | ﹤0.01% |
12,205
-3,674
| -23% | -$50.4K |
|
3629
PUT
Kyndryl
KD
$2.78B
| $186K | ﹤0.01% |
14,000
| – | – |
|
3630
Solid Power Inc Warrant
SLDPW
$5.67M
| $185K | ﹤0.01% |
604,873
| – | – |
|
|
KNTE
3631
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $182K | ﹤0.01% |
+60,109
| New | +$232K |
|
3632
Adtran
ADTN
$628M
| $181K | ﹤0.01% |
+17,152
| New | +$170K |
|
|
DOYU
3633
DouYu International Holdings
DOYU
$128M
| $180K | ﹤0.01% |
17,147
-6,510
| -28% | -$69.4K |
|
3634
Telephone and Data Systems
TDS
$3.81B
| $180K | ﹤0.01% |
21,821
-13,071
| -37% | -$111K |
|
3635
Crescent Capital BDC
CCAP
$396M
| $179K | ﹤0.01% |
+11,800
| New | +$165K |
|
|
MTA
3636
Metalla Royalty & Streaming
MTA
$1.06B
| $177K | ﹤0.01% |
40,771
-62,258
| -60% | -$297K |
|
|
EQRXW
3637
DELISTED
EQRx, Inc. Warrant
EQRXW
| $176K | ﹤0.01% |
1,097,439
| – | – |
|
3638
Sabre
SABR
$912M
| $175K | ﹤0.01% |
55,007
-21,549
| -28% | -$77.9K |
|
|
AKTS
3639
DELISTED
Akoustis Technologies Inc
AKTS
| $175K | ﹤0.01% |
55,106
-52,976
| -49% | -$162K |
|
3640
Lineage Cell Therapeutics
LCTX
$276M
| $173K | ﹤0.01% |
+122,681
| New | +$170K |
|
3641
PUT
Comstock Resources
CRK
$4.19B
| $173K | ﹤0.01% |
14,900
-201,400
| -93% | -$2.1M |
|
3642
Pearson
PSO
$10B
| $172K | ﹤0.01% |
+16,398
| New | +$169K |
|
|
BLFY
3643
DELISTED
Blue Foundry Bancorp
BLFY
| $170K | ﹤0.01% |
+16,857
| New | +$162K |
|
3644
Barnes & Noble Education
BNED
$430M
| $169K | ﹤0.01% |
1,344
-434
| -24% | -$60.7K |
|
|
SCU
3645
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $169K | ﹤0.01% |
19,132
-1,900
| -9% | -$16.5K |
|
3646
Oportun Financial
OPRT
$350M
| $168K | ﹤0.01% |
28,184
+17,412
| +162% | +$85.5K |
|
3647
CALL
Bumble
BMBL
$376M
| $168K | ﹤0.01% |
10,000
| – | – |
|
3648
1stdibs.com
DIBS
$157M
| $167K | ﹤0.01% |
44,632
-224
| -0.5% | -$853 |
|
|
FPI
3649
Farmland Partners
FPI
$452M
| $166K | ﹤0.01% |
13,600
-146,593
| -92% | -$1.64M |
|
3650
QuantumScape Corp
QS
$3.52B
| $165K | ﹤0.01% |
20,661
-198,580
| -91% | -$1.38M |
|
Similar funds
David Shaw's Q2 2023 Portfolio in Review
As of Q2 2023, David Shaw held 4,841 positions worth $97.9B, up 4.8% from $93.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $4.46B in Q2 2023, closing 639 positions and reducing 1,586 holdings. Its most notable exit was Shaw Communications Inc., an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Oracle worth $217M.
- David Shaw's largest Q2 2023 buy was Oracle: 1,825,762 shares worth $217M.
- David Shaw added most to NVIDIA in Q2 2023, an estimated $997M increase.
- David Shaw's biggest Q2 2023 reduction was Visa, cutting an estimated $547M.
- David Shaw fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $152M.
- David Shaw's ten largest holdings make up 12% of its $97.9B portfolio in Q2 2023.
- David Shaw opened 467 new positions and closed 639 in Q2 2023.
- David Shaw's portfolio value rose 4.8% quarter-over-quarter to $97.9B.
Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.